Nature Communications · 2018 · 73 citations · 44 references
MedicineImmunologyOncologyCancer ImmunologyMolecular OncologyTumor MicroenvironmentCancer Cell SignalingCancer TranscriptomicsInflammatory SignalingOncogenic Signaling PathwaysRas Family OncogenesTumor Microenvironment ModulationEstrogen Receptor SignalingImmunomodulatory CytokinesLung Tumor PromotionOncogenic Ras SignalingOncogenic Signaling NetworksStat3 SignalingTumor Microenvironment EffectsTumor Microenvironment Modeling
Abstract Lung adenocarcinomas (LUADs) with mutations in the K-ras oncogene display dismal prognosis. Proinflammatory and immunomodulatory events that drive development of K-ras mutant LUAD are poorly understood. Here, we develop a lung epithelial specific K-ras mutant/ Stat3 conditional knockout (LR/ Stat3 Δ/Δ ) mouse model. Epithelial Stat3 deletion results in intriguing sex-associated discrepancies; K-ras mutant tumors are decreased in female LR/ Stat3 Δ/Δ mice whereas tumor burdens are increased in males. RNA-sequencing and tumor microenvironment (TME) analysis demonstrate increased anti-tumor immune responses following Stat3 deletion in females and, conversely, elevated pro-tumor immune pathways in males. While IL-6 blockade in male LR/ Stat3 Δ/Δ mice reduces lung tumorigenesis, inhibition of estrogen receptor signaling in female mice augments K-ras mutant oncogenesis and reprograms lung TME toward a pro-tumor phenotype. Our data underscore a critical sex-specific role for epithelial Stat3 signaling in K-ras mutant LUAD, thus paving the way for developing personalized (e.g. sex-based) immunotherapeutic strategies for this fatal disease.
44
Rebecca L. Siegel, Kimberly D. Miller, Ahmedin Jemal · CA A Cancer Journal for Clinicians · 2017 · 15K citations · Full text
Neutrophil elastase–mediated degradation of IRS-1 accelerates lung tumor growth
A. McGarry Houghton, Danuta M. Rzymkiewicz, Hongbin Ji et al. · Nature Medicine · 2010 · 735 citations · Full text
Medicine, Immunology, Oncology +16